Jose R. Mas's most recent trade in Aptiv PLC was a trade of 31,568 Ordinary Shares done at an average price of $73.5 . Disclosure was reported to the exchange on Feb. 28, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aptiv | Joseph R. Massaro | Vice Chair & President, ECG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.54 per share. | 28 Feb 2026 | 31,568 | 311,596 (0%) | 0% | 73.5 | 2,321,511 | Ordinary Shares |
| Aptiv | Joseph R. Massaro | Vice Chair & President, ECG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2026 | 13,772 | 343,164 (0%) | 0% | 0 | Ordinary Shares | |
| Mastec Inc | Jose R. Mas | Director, CEO | Other type of transaction at price $ 0.00 per share. | 21 Aug 2025 | 364,850 | 0 | - | - | Forward sale contract (potential obligation to sell) | |
| Mastec Inc | Jose R. Mas | Director, CEO | Other type of transaction at price $ 0.00 per share. | 21 Aug 2025 | 340,794 | 340,794 | - | - | Forward sale contract (potential obligation to sell) | |
| Aptiv | Joseph R. Massaro | Vice Chairman, ECG | Sale of securities on an exchange or to another person at price $ 74.36 per share. | 21 Aug 2025 | 35,000 | 329,392 (0%) | 0% | 74.4 | 2,602,600 | Ordinary Shares |
| Avantor Inc | Joseph R. Massaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 17,100 | 52,138 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc | Joseph R. Massaro | Director | Purchase of securities on an exchange or from another person at price $ 12.30 per share. | 29 Apr 2025 | 8,100 | 35,038 (0%) | 0% | 12.3 | 99,630 | Common Stock |
| Mastec Inc | Jose R. Mas | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 124.03 per share. | 24 Mar 2025 | 23,691 | 3,256,248 (4%) | 0% | 124.0 | 2,938,395 | Common Stock |
| Mastec Inc | Jose R. Mas | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2025 | 61,713 | 3,279,939 (4%) | 0% | 0 | Common Stock | |
| Helmerich & Payne Inc | Jose R. Mas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 7,177 | 38,024 (0%) | 0% | 0 | Common Stock | |
| Aptiv | Joseph R. Massaro | Vice Chairman, ECG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 79,556 | 364,392 (0%) | 0% | 0 | Ordinary Shares | |
| Aptiv | Joseph R. Massaro | Vice Chairman, ECG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 37,527 | 284,836 (0%) | 0% | 0 | Ordinary Shares | |
| Aptiv | Joseph R. Massaro | Vice Chairman, ECG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.12 per share. | 28 Feb 2025 | 16,068 | 247,309 (0%) | 0% | 65.1 | 1,046,348 | Ordinary Shares |
| Aptiv | Joseph R. Massaro | Vice Chairman, ECG | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2025 | 8,010 | 263,377 (0%) | 0% | 0 | Ordinary Shares | |
| Mastec Inc | Jose R. Mas | Director, CEO | 09 Sep 2024 | 387,500 | 0 | - | - | Forward sale contract (potential obligation to sell) | ||
| Mastec Inc | Jose R. Mas | Director, CEO | 09 Sep 2024 | 364,850 | 364,850 | - | - | Forward sale contract (potential obligation to sell) | ||
| Avantor Inc | Joseph R. Massaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 8,477 | 26,938 (0%) | 0% | 0 | Common Stock | |
| Mastec Inc | Jose R. Mas | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.36 per share. | 18 Mar 2024 | 21,057 | 3,218,226 (4%) | 0% | 86.4 | 1,818,483 | Common Stock |
| Mastec Inc | Jose R. Mas | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 81,037 | 3,239,283 (4%) | 0% | 0 | Common Stock | |
| Aptiv | R. Massaro Joseph | CFO and SVP, Business Ops | 28 Feb 2024 | 47,869 | 271,387 (0%) | 0% | 0 | Ordinary Shares | ||
| Aptiv | Massaro R. Joseph | CFO and SVP, Business Ops | 28 Feb 2024 | 31,912 | 223,518 (0%) | 0% | 0 | Ordinary Shares | ||
| Aptiv | R. Joseph Massaro | CFO and SVP, Business Ops | 28 Feb 2024 | 12,843 | 191,606 (0%) | 0% | 78.8 | 1,011,643 | Ordinary Shares | |
| Helmerich & Payne Inc | Jose R. Mas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 4,675 | 30,847 (0%) | 0% | 0 | Common Stock | |
| Aptiv | R. Massaro Joseph | CFO and SVP, Business Ops | 28 Feb 2024 | 2,324 | 204,449 (0%) | 0% | 0 | Ordinary Shares | ||
| Aptiv | Joseph R. Massaro | CFO and SVP, Business Ops | 15 Sep 2023 | 1,900 | 206,773 (0%) | 0% | 101.9 | 193,553 | Ordinary Shares | |
| Avantor Inc | Joseph R. Massaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 9,808 | 18,461 (0%) | 0% | 0 | Common Stock | |
| Mastec Inc | Jose R. Mas | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.09 per share. | 19 Mar 2023 | 63,212 | 3,158,246 (4%) | 0% | 87.1 | 5,505,133 | Common Stock |
| Mastec Inc | Jose R. Mas | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 72,902 | 3,221,458 (4%) | 0% | 0 | Common Stock | |
| Helmerich & Payne Inc | Jose R. Mas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 4,197 | 26,172 (0%) | 0% | 0 | Common Stock | |
| Aptiv | Joseph R. Massaro | CFO and SVP, Business Ops | 28 Feb 2023 | 29,302 | 208,673 (0%) | 0% | 0 | Ordinary Shares | ||
| Aptiv | Joseph R. Massaro | CFO and SVP, Business Ops | 28 Feb 2023 | 20,393 | 159,836 (0%) | 0% | 116.3 | 2,371,298 | Ordinary Shares | |
| Aptiv | Joseph R. Massaro | CFO and SVP, Business Ops | 28 Feb 2023 | 19,535 | 179,371 (0%) | 0% | 0 | Ordinary Shares | ||
| Mastec Inc | Jose R. Mas | Director, CEO | 10 Jan 2023 | 775,000 | 775,000 | - | - | Forward sale contract (potential obligation to sell) | ||
| Mastec Inc | Jose R. Mas | Director, CEO | 10 Jan 2023 | 387,500 | 387,500 | - | - | Forward sale contract (potential obligation to sell) | ||
| Mastec Inc | Jose R. Mas | Director, CEO | 10 Jan 2023 | 212,500 | 0 | - | - | Forward sale contract (potential obligation to sell) | ||
| Aptiv | Joseph R. Massaro | CFO and SVP, Business Ops | 01 Sep 2022 | 1,900 | 180,229 (0%) | 0% | 91.9 | 174,553 | Ordinary Shares | |
| Avantor Inc | Joseph R. Massaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 6,693 | 8,653 (0%) | 0% | 0 | Common Stock | |
| Avantor Inc | Joseph R. Massaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 1,215 | 1,960 (0%) | 0% | 0 | Common Stock | |
| Mastec Inc | Jose R. Mas | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 63,277 | 3,231,830 (4%) | 0% | 0 | Common Stock | |
| Mastec Inc | Jose R. Mas | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.85 per share. | 14 Mar 2022 | 24,029 | 3,168,553 (4%) | 0% | 82.9 | 1,990,803 | Common Stock |
| Helmerich & Payne Inc | Jose R. Mas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 4,733 | 21,975 (0%) | 0% | 0 | Common Stock | |
| Aptiv | Joseph R. Massaro | CFO and SVP, Business Ops | 28 Feb 2022 | 21,650 | 182,129 (0%) | 0% | 0 | Ordinary Shares | ||
| Aptiv | Joseph R. Massaro | CFO and SVP, Business Ops | 28 Feb 2022 | 16,216 | 146,046 (0%) | 0% | 129.4 | 2,098,999 | Ordinary Shares | |
| Aptiv | Joseph R. Massaro | CFO and SVP, Business Ops | 28 Feb 2022 | 14,433 | 160,479 (0%) | 0% | 0 | Ordinary Shares | ||
| Aptiv | Joseph R. Massaro | CFO and SVP, Business Ops | 28 Feb 2022 | 1,655 | 162,262 (0%) | 0% | 0 | Ordinary Shares | ||
| Aptiv | Joseph R. Massaro | CFO and SVP, Business Ops | 28 Feb 2022 | 313 | 0 | - | - | Dividend Equivalent Right | ||
| Aptiv | Joseph R. Massaro | CFO and SVP, Business Ops | 28 Feb 2022 | 313 | 163,917 (0%) | 0% | 0 | Ordinary Shares | ||
| Avantor Inc | Joseph R. Massaro | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2021 | 745 | 745 (0%) | 0% | 0 | Common Stock | |
| Aptiv | Joseph R. Massaro | CFO and SVP, Business Ops | 15 Sep 2021 | 1,600 | 163,604 (0%) | 0% | 150.3 | 240,544 | Ordinary Shares | |
| Mastec Inc | Jose R. Mas | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2021 | 57,926 | 3,192,582 (4%) | 0% | 0 | Common Stock | |
| Mastec Inc | Jose R. Mas | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.93 per share. | 14 Mar 2021 | 18,798 | 3,134,656 (4%) | 0% | 98.9 | 1,859,686 | Common Stock |
| Mastec Inc | Jose R. Mas | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2021 | 2,500 | 3,153,454 (4%) | 0% | 0 | Common Stock |